524 related articles for article (PubMed ID: 31582021)
1. Hormone Therapy for Transgender Adults.
Radix A
Urol Clin North Am; 2019 Nov; 46(4):467-473. PubMed ID: 31582021
[TBL] [Abstract][Full Text] [Related]
2. MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people.
Glintborg D; T'Sjoen G; Ravn P; Andersen MS
Eur J Endocrinol; 2021 Jun; 185(2):R49-R63. PubMed ID: 34081614
[TBL] [Abstract][Full Text] [Related]
3. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
[TBL] [Abstract][Full Text] [Related]
4. Gender-Affirming Hormone Use in Transgender Individuals: Impact on Behavioral Health and Cognition.
Nguyen HB; Chavez AM; Lipner E; Hantsoo L; Kornfield SL; Davies RD; Epperson CN
Curr Psychiatry Rep; 2018 Oct; 20(12):110. PubMed ID: 30306351
[TBL] [Abstract][Full Text] [Related]
5. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.
Rowniak S; Bolt L; Sharifi C
JBI Database System Rev Implement Rep; 2019 Sep; 17(9):1826-1854. PubMed ID: 31021971
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular implications of gender-affirming hormone treatment in the transgender population.
Dutra E; Lee J; Torbati T; Garcia M; Merz CNB; Shufelt C
Maturitas; 2019 Nov; 129():45-49. PubMed ID: 31547912
[TBL] [Abstract][Full Text] [Related]
7. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
[TBL] [Abstract][Full Text] [Related]
8. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Smith KP; Madison CM; Milne NM
Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study.
Aldridge Z; Patel S; Guo B; Nixon E; Pierre Bouman W; Witcomb GL; Arcelus J
Andrology; 2021 Nov; 9(6):1808-1816. PubMed ID: 32777129
[TBL] [Abstract][Full Text] [Related]
10. Endocrinology of Transgender Medicine.
T'Sjoen G; Arcelus J; Gooren L; Klink DT; Tangpricha V
Endocr Rev; 2019 Feb; 40(1):97-117. PubMed ID: 30307546
[TBL] [Abstract][Full Text] [Related]
11. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function.
Schneider F; Kliesch S; Schlatt S; Neuhaus N
Andrology; 2017 Sep; 5(5):873-880. PubMed ID: 28914501
[TBL] [Abstract][Full Text] [Related]
12. Referrals For Gender-Affirming Hormone Treatment in Croatia's National Network for Transgender Healthcare.
Altabas V; Galjuf V; Žegura I; Jokić Begić N; Moravek D; Arbanas G; Begić D
Arch Sex Behav; 2024 Jun; 53(6):2045-2052. PubMed ID: 38691268
[TBL] [Abstract][Full Text] [Related]
13. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
[TBL] [Abstract][Full Text] [Related]
14. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
15. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
[TBL] [Abstract][Full Text] [Related]
16. Sexual Dysfunction in Transgender People: A Systematic Review.
Mattawanon N; Charoenkwan K; Tangpricha V
Urol Clin North Am; 2021 Nov; 48(4):437-460. PubMed ID: 34602167
[TBL] [Abstract][Full Text] [Related]
17. Current Treatment Regimens for Transfeminine Individuals in the Nordic Countries.
Hojbjerg JA; Saini SL; Hvas AM; Hojgaard AD
J Sex Med; 2021 Mar; 18(3):656-663. PubMed ID: 33582008
[TBL] [Abstract][Full Text] [Related]
18. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
19. Transgender health and the impact of aging and menopause.
Cheung AS; Nolan BJ; Zwickl S
Climacteric; 2023 Jun; 26(3):256-262. PubMed ID: 37011669
[TBL] [Abstract][Full Text] [Related]
20. Gender dysphoria and children.
Nicholson C; McGuinness TM
J Psychosoc Nurs Ment Health Serv; 2014 Aug; 52(8):27-30. PubMed ID: 24972388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
